Tesamorelin, a lab-created peptide analog of growth hormone-releasing hormone (GHRH) , is mainly utilized in the handling of visceral adipose tissue in individuals suffering from HIV. This drug works by stimulating the secretion of growth hormone from the pituitary structure, which in effect can aid in reducing abdominal fat accumulation . While no

Emerging retatrutide, a combined-action drug targeting simultaneously GLP-1 and GIP receptors, is creating considerable interest within the healthcare community. Early clinical research have revealed significant losses in body weight and advancements in physiological markers for patients with obesity . Experts believe this novel approach could repr